Characterization of two novel mutations of the antithrombin gene observed in Japanese thrombophilic patients

Thrombosis Research

Volumn 115, Issue 5, 2005, Pages 351-358

  Kurihara, Masako ^a   Watanabe, Kumiko ^a   Inoue, Sumiko ^a   Wada, Yui ^a   Ono, Miyuki ^a   Wakiyama, Machiko ^a   Iida, Hiroko ^a   Kinoshita, Sachiko ^a   Hamasaki, Naotaka ^a  

^a KYUSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

20210A; Deep vein thrombosis; Factor V Leiden; Gene analysis; Structure and function of antithrombin

Indexed keywords

ANTITHROMBIN;

ADULT; ANTITHROMBIN DEFICIENCY; ARTICLE; CASE REPORT; EXON; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC TRANSFECTION; HETEROZYGOSITY; HUMAN; HUMAN CELL; MALE; MOLECULAR DYNAMICS; PREDICTION; PRIORITY JOURNAL; WILD TYPE;

EID: 14144253583     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2004.08.025     Document Type: Article

References (40)

1. G. Murano, L. Williams, M. Miller-Andersson, D.L. Aronson, and C. King Some properties of antithrombin-III and its concentration in human plasma Thromb. Res. 18 1980 259 262
2. E.F. Mammen Antithrombin: its physiological importance and role in DIC Semin. Thromb. Hemost. 24 1998 19 25
3. L.-E. Franzen, S. Svensson, and O. Larm Structual studies on the carbohydrate portion of human antithrombin J. Biol. Chem. 255 1980 5090 5093
4. E.V. Prochownik, A.F. Markham, and S.H. Orkin Isolation of a cDNA clone for human antithrombin J. Biol. Chem. 258 1983 8389 8394
5. J.A. Huntington, R.J. Read, and R.W. Carrell Structure of a serpin-protease complex shows inhibition by deformation Nature 407 2000 923 926
6. P.E. Stein, and R.W. Carrell What do dysfunctional serpin tell us about molecular mobility and diseases? Struct. Biol. 2 1995 96 113
7. H.T. Wright, and J.N. Scarsdale Structual basis for serpin inhibitor activity Proteins 22 1995 210 225
8. J. Whisstock, R. Skinner, and A.M. Lesk An atlas of serpin conformations Trends Biochem. Sci. 23 1998 63 67
9. E. Stratikos, and P.G. Gettins Formation of the covalent serpin-proteinase complex involves translocation of the proteinase by more than 70A and full insertion of the reactive center loop into beta-sheet A Proc. Natl. Acad. Sci. U. S. A. 96 1999 4808 4813
10. I. Bjork, A. Danielsson, J.W. Fenton, and H. Jornvall The site in human antithrombin for functional proteolytic cleavage by human thrombin FEBS Lett. 126 1981 257 260
11. I. Bjork, C.M. Jackson, H. Jornvall, K.K. Lavine, K. Nordling, and W.J. Salsgive The active site of antithrombin. Release of the same proteolytically cleaved form of the inhibitor from complexes with factor χa, factor χa, and thrombin J. Biol. Chem. 257 1982 2406 2411
12. H. Loebermann, R. Tokuoka, J. Deisenhofer, and R. Huber Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function J. Mol. Biol. 177 1984 531 557
13. R.D. Rosenberg, and P.S. Damus The purification and mechanism of action antithrombinheparin cofactor J. Biol. Chem. 248 1973 6490 6505
14. R.J. Olds, D.A. Lane, V. Chowdhury, V. De Stefano, G. Leone, and S.L. Thein Complete nucleotide sequence of the antithrombin gene: evidence for homologous recombination causing thrombophilia Biochemistry 32 1993 4216 4224
15. O. Egeberg Inherited antithrombin deficiency causing thrombophilia Thromb. Diath. Haemorrh. 13 1965 516 530
16. G. Sas, G. Blasko, and D. Banhegyi Abnormal antithrombin III (Antithrombin III "Budapest") as a cause of familial thrombophilia Thromb. Diath. Haemorrh. 32 1974 105 115
17. E. Thaler, and K. Lechner Antithrombin III deficiency and thromboembolism Clin. Haematol. 10 1981 369 390
18. G. Finazzi, T.H. Tran, T. Barbui, and B. Duckert Purification of antithrombin 'Vicenza': a molecule with normal heparin affinity and impaired reactivity to thrombin Br. J. Haematol. 59 1985 259 263
19. J. Hirsh, F. Piovella, and M. Pini Congenital antithrombin III deficiency: incidence and clinical features Am. J. Med. 87 1989 34 38
20. R. Caso, D.A. Lane, E.A. Thompson, R.J. Olds, S.L. Thein, and M. Panico Antithrombin Vicenza, Ala 384 to Pro (GCA to CCA) mutation, transforming the inhibitor into a substrate Br. J. Haematol. 77 1991 87 92
21. C. Demers, J.S. Ginsberg, J. Hirsh, P. Henderson, and M.A. Blajchman Thrombosis in antithrombin III-deficient persons: report of a large kindred and Literature review Ann. Intern. Med. 116 1992 754 761
22. M. Aiach, S. Gandrille, and J. Emmerich A review of mutations causing deficiencies of antithrombin, protein C, protein S Thromb. Haemost. 74 1995 81 89
23. H. Tsuda, S. Hattori, S. Tanabe, H. Iida, M. Nakahara, and S. Nishioka Screening for aetiology of thrombophilia: a high prevalence of protein S abnormality Ann. Clin. Biochem. 36 1999 423 432
24. H. Iida, M. Nakahara, K. Komori, M. Fujise, M. Wakiyama, and M. Urata Failure in the detection of aberrant mRNA from the heterozygotic splice site mutant allele for protein S in a patient with protein S deficiency Thromb. Res. 102 2001 187 196
25. R.R. Finan, H. Tamim, G. Ameen, H.E. Sharida, M. Rashid, and W.Y. Almawi Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population Am. J. Hematol. 71 2002 300 305
26. S. Ho, H. Hunt, R. Horton, J. Pullen, and L. Pease Site-directed mutagenesis by overlap extension using the polymerase chain reaction Gene 77 1989 51 59
27. L. Jin, J.P. Abrahams, R. Skinner, M. Petitou, R.N. Pike, and R.W. Carrell The anticoagulant activation of antithrombin by heparin Proc. Natl. Acad. Sci. U. S. A. 94 1997 14683 14688
28. R.N. Pike, J. Potempa, R. Skinner, H.L. Fitton, W.T. McGraw, and J. Travis Heparin dependent modification of the reactive center arginine of antithrombin and cosequent increase in heparin binding affinity J. Biol. Chem. 272 1997 19652 19655
29. J.A. Huntington, S.T. Olson, B. Fan, and P.G. Gettins Mechanism of heparin activation of antithrombin. Evidence for reactive center loop preinsertion with expulsion upon heparin binding Biochemistry 35 1996 8495 8503
30. A.J. McCoy, X.Y. Pei, R. Skinner, J.P. Abrahams, and R.W. Carrell Structure of betaantithrombin and the effect of glycosylation on antithrombin's heparin affinity and activity J. Mol. Biol. 326 2003 823 833
31. J.A. Huntington, A. McCoy, K.J. Belzar, X.Y. Pei, P.G. Gettins, and R.W. Carrell The conformational activation of antithrombin. A 2.85-Å structure of a fluorescein derivative reveals an electrostatic link between the hinge and heparin binding regions J. Biol. Chem. 275 2000 15377 15383
32. D.A. Lane, T. Bayston, R.J. Olds, A.C. Fitches, D.N. Cooper, and D.S. Millar Antithrombin mutation database: 2nd update. For the plasma coagulation inhibitors subcommittee of the Scientific and Standardization Committee of international Society on Thrombosis and Haemostasis Thromb. Haemost. 77 1997 197 211
33. R. Huber, and R.W. Carrell Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins Biochemistry 28 1989 8951 8966
34. K. Skriver, W.R. Wikoff, P.A. Patston, P.A. Pataton, F. Tausk, and M. Schapira Substrate properties of C1 inhibitor Ma (alanine 434-glutamic acid). Genetic and structural evidence suggesting that the P12-region contains critical determinants of serineprotease inhibitor/substrate status J. Biol. Chem. 266 1991 9216 9221
35. R. Devraj-Kizuk, D.H.K. Chui, E.V. Prochownik, C.J. Carter, F.A. Ofosu, and M.A. Blajchman Antithrombin III Hamilton: a gene with a point mutation (guanine to adenine) in codon 382 causing impaired serine protease reactivity Blood 72 1988 1518 1523
36. R.C. Austin, R.A. Rachubinski, F.A. Ofosu, and M.A. Blajchman Antithrombin-III-Hamilton, Ala 382 to Thr: an Antithrombin-IIIvariant that acts a substrate but not an inhibitor of alpha-thrombin and Factor χa Blood 77 1991 2185 2189
37. H. Ireland, D.A. Lane, E. Thompson, I.D. Walker, I. Blench, and H.R. Morris Antithrombin Glasgow II: alanine 382 to threonine mutation in the serpin P12 position, resulting in a substrate reaction with thrombin Br. J. Haematol. 79 1991 70 74
38. D.J. Johnson, and J.A. Huntington The influence of hinge region residue Glu-381 on antithrombin allostery and metastability J. Biol. Chem. 279 2004 4913 4921
39. A. Zhou, R.W. Carrell, and J.A. Huntington The serpin inhibitory mechanism is critically dependent on the length of the reactive center loop J. Biol. Chem. 276 2001 27541 27547
40. S. Kondo, F. Tokunaga, K. Kario, T. Matsuo, and T. Koide Molecular and cellular basis for type 1 heparin cofactor IIdeficiency (Heparin CofactorIIAwaji) Blood 87 1996 1006 1012